You are here:Home-Chemical Inhibitors & Agonists-Metabolic Enzyme/Protease-NAMPT-GNE-617
GNE-617

Chemical Structure : GNE-617

CAS No.: 1362154-70-8

GNE-617 (GNE617)

Catalog No.: PC-38786Not For Human Use, Lab Use Only.

GNE-617 is a potent, selective, cellularly active NAMPT inhibitor with IC50 of 5 nM, inhibits multiple cancer cell lines (U251, HT1080, PC3, MiaPaCa2, and HCT116 lines) with IC50 of <10 nM.

Packing Price Stock Quantity
10 mg $118 In stock
25 mg $188 In stock
50 mg $298 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

GNE-617 is a potent, selective, cellularly active NAMPT inhibitor with IC50 of 5 nM, inhibits multiple cancer cell lines (U251, HT1080, PC3, MiaPaCa2, and HCT116 lines) with IC50 of <10 nM.
GNE-617 displayed acceptable mouse PK properties (F = 41%, CL = 52.4 mL/min/kg), and exhibited robust efficacy in a U251 mouse xenograft model.

Physicochemical Properties

M.Wt 427.43
Formula C21H15F2N3O3S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-[[4-[(3,5-Difluorophenyl)sulfonyl]phenyl]methyl]imidazo[1,2-a]pyridine-6-carboxamide

References

1. Yauch RL, et al. Clin Cancer Res. 2013 Dec 15;19(24):6912-23.

2. O'Brien T, et al. Neoplasia. 2013 Dec;15(12):1314-29.

3. Zheng X, et al. J Med Chem 2013;56:6413–33.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: